However, the observation made by Salama et al. [33] that displays better survival outcome for colorectal cancer patients with a high density of FOXP3 is therefore counter-intuitive and contrasts with what has been reported for other solid tumor types, including melanoma, breast, ovarian, hepatocellular, and pancreatic cancers. This evidence concerns the gene FOXP3 and melanoma.